Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

How Pharma Will Be Impacted by Trump’s Healthcare Reform Plans

Posted on November 25th, 2016 by in Pharma R&D

It has only been a couple of days since Donald Trump was elected President of the United States, but the pharmaceutical and biotech industries are already wondering what might be in store for them in 2017. Continue reading “How Pharma Will Be Impacted by Trump’s Healthcare Reform Plans” »

What Does the 2016 US Election Mean For Pharma?

Posted on June 28th, 2016 by in Pharma R&D

With summer, the 2016 U.S. Presidential Election is now truly heating up as we have presumptive nominees from the two major political parties. While we are hearing a lot about issues like national security and immigration from Republican nominee Donald Trump and Democratic nominee Hillary Clinton, those working in the pharmaceutical industry may be wondering how their sector will be affected by the eventual winner. Continue reading “What Does the 2016 US Election Mean For Pharma?” »